Rapid test for the qualitative detection of antigens of adenovirus, respiratory syncytial virus, and influenza viruses A and B
Express test for adenovirus, respiratory syncytial virus (RSV), influenza A and B, COVID-19, and mycoplasma pneumoniae
Acute respiratory infections can have similar symptoms, including fever, runny nose, cough, sore throat, and general weakness. At the same time, various viruses can be responsible for the illness, requiring different approaches to treatment.
The express test for the qualitative detection of antigens of adenovirus, respiratory syncytial virus (RSV), influenza viruses A and B, COVID-19, and mycoplasma pneumoniae helps determine whether the antigens of these pathogens are present in the tested sample. The test results assist the doctor in specifying the possible cause of the symptoms and determining the further strategy for examination and treatment.
Which viruses does the test detect?
The test is designed to detect antigens of five common respiratory viruses and one bacterial infection:
- Adenovirus. Can cause respiratory infections, pharyngitis, fever, and sometimes conjunctivitis.
- Respiratory Syncytial Virus (RSV). Often causes respiratory tract infections. Its detection is particularly important in infants and young children, where the infection can be complicated by bronchiolitis.
- Influenza Virus A. Can cause a sudden onset of illness with high fever, headache and muscle pain, cough, and significant weakness.
- Influenza Virus B. Also causes flu-like symptoms and can lead to complications.
- SARS-CoV-2 (COVID-19). Can cause fever, cough, sore throat, weakness, and other respiratory symptoms.
- Mycoplasma pneumoniae. This is a bacterium that can cause respiratory tract infections, including tracheobronchitis and pneumonia. The disease is often accompanied by a prolonged cough.
When is testing recommended?
Testing may be warranted in the presence of symptoms of acute respiratory infection, including:
- fever;
- cough, runny or stuffy nose;
- pain or irritation in the throat;
- headache and general weakness;
- muscle pain, chills;
- difficulty breathing or wheezing, especially in children.
The appropriateness of testing is determined by a healthcare provider considering the symptoms, patient age, and disease course.
How is the study conducted?
For the test, a sample is taken from the respiratory tract, usually a swab from the nose or nasopharynx. The exact type of sample depends on the test system used by the laboratory.
The study allows for the qualitative detection of the antigens of the relevant viruses/bacteria. The duration of the test and the receipt of results depend on the specific test system used.
What do the test results mean?
A positive result indicates the detection of the antigen of one or several viruses/bacteria that the test detects. The result is evaluated in conjunction with symptoms and examination findings.
A negative result means that the antigens of the tested viruses/bacteria were not detected in the sample. However, it does not always completely rule out an infection. The result may be influenced by the time elapsed since the onset of illness, the quality of the sample collection, and the sensitivity of the test system. If symptoms persist or there is suspicion of infection, the doctor may recommend additional molecular testing, such as PCR.
It is important to remember that the test detects only those pathogens included in its configuration. A negative result does not exclude other causes of respiratory illness.
Why is it important to identify the pathogen?
Identifying the likely cause of the infection helps the healthcare provider choose the subsequent management strategy for the patient. In particular, confirmation of influenza may affect the decision to prescribe antiviral therapy, especially for individuals at increased risk of complications.
At the same time, the test result does not replace a doctor's consultation and does not rule out the possibility of the simultaneous presence of another infection.
You can undergo a rapid test for adenovirus, RSV, influenza viruses A and B, COVID-19, and Mycoplasma pneumoniae at the “Dobrobut” medical center. Consult a physician to determine the appropriateness of the study and receive recommendations based on symptoms and health status.